financetom
Business
financetom
/
Business
/
Correction: Zscaler Fiscal Q4 Non-GAAP EPS, Sales Increase; Shares Sink Premarket Amid Lower-Than-Expected Fiscal Q1 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Correction: Zscaler Fiscal Q4 Non-GAAP EPS, Sales Increase; Shares Sink Premarket Amid Lower-Than-Expected Fiscal Q1 Outlook
Sep 6, 2024 12:08 PM

06:51 AM EDT, 09/04/2024 (MT Newswires) -- (Corrects first paragraph to reflect Q1, full-year guidance missing analyst estimates)

Zscaler (ZS) shares were down more than 15% in premarket activity Wednesday after the company reported overnight lower-than-expected guidance for non-GAAP earnings for fiscal Q1 and the full financial year 2025, taking the shine out of its fiscal Q4 beat.

The company reported fiscal Q4 non-GAAP earnings late Tuesday of $0.88 per diluted share, up from $0.64 a year earlier.

Analysts polled by Capital IQ expected $0.69.

Revenue for the quarter ended July 31 was $592.9 million, up from $455.0 million a year earlier.

Analysts surveyed by Capital IQ expected $567.6 million.

The company expects Q1 non-GAAP EPS of about $0.62 to $0.63 and revenue of $604 million to $606 million.

Analysts polled by Capital IQ expect $0.72 and $602.1 million, respectively.

The company expects fiscal 2025 non-GAAP EPS of $2.81 to $2.87 and revenue of $2.60 billion to $2.62 billion.

Analysts surveyed by Capital IQ expect $3.28 and $2.62 billion, respectively.

Price: 161.34, Change: -31.85, Percent Change: -16.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BMO on BRP's First Quarter Result
BMO on BRP's First Quarter Result
Jun 3, 2024
02:29 PM EDT, 06/03/2024 (MT Newswires) -- BRP's first quarter result was in line, but FY 2025 guidance, particularly second quarter expectations, was lowered to reflect ongoing caution from its dealer network and retail softness in Seasonal Products and Marine, notes BMO. Despite guidance being cut again, BMO thinks the company is making the right decision to further reduce channel...
Rapport Therapeutics to Price IPO at $16 to $18 per Share
Rapport Therapeutics to Price IPO at $16 to $18 per Share
Jun 3, 2024
02:25 PM EDT, 06/03/2024 (MT Newswires) -- Rapport Therapeutics expects to price its initial public offering of 8 million shares between $16 and $18 per share, according to a securities filing Monday. The stock will start trading on Nasdaq under the symbol RAPP. The underwriters can purchase up to an additional 1.2 million shares. Proceeds from the IPO will be...
Why Is German Biotech Affimed Stock Soaring On Monday?
Why Is German Biotech Affimed Stock Soaring On Monday?
Jun 3, 2024
Affimed N.V. ( AFMD ) shares are trading higher on Monday. On Saturday, the company announced longer follow-up data from the EGFRwt cohort and initial clinical efficacy data from the EGFRmut cohort from the ongoing AFM24-102 study in non-small cell lung cancer (NSCLC). As of the updated data cutoff on May 13, for the 17 EGFRwt patients previously reported, 15 patients were response-evaluable. Four confirmed...
Former TD employee in Florida accused of opening fraudulent accounts, Bloomberg News reports
Former TD employee in Florida accused of opening fraudulent accounts, Bloomberg News reports
Jun 3, 2024
(Reuters) -A former TD Bank employee falsified documents to open dozens of accounts and provided concierge-like services to help cash flow across borders, Bloomberg News reported on Monday. Gerry Aquino Vargas, the now-former retail banker in Hollywood, Florida, an outpost of TD Bank, took a series of $200 bribes to help clients move millions to Colombia by skirting anti-money-laundering defenses,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved